Company: BNBX
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001410578-25-001814
Chunk: 8

Company: BNB PLUS CORP.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part II, Item 6E
Chunk 8
---
Item 6. — Exhibits.

​​​​​​​​​​​​​​​​Incorporated by Reference to SEC Filing​Filed or Furnished withExhibit​​​​​Exhibit​​​​​this FormNo.    Filed Exhibit Description    Form    No.    File No.    Date Filed    10-Q3.1​Conformed version of Certificate of Incorporation of Applied DNA Sciences, Inc., as most recently amended by the Eighth Certificate of Amendment, effective June 2, 2025​S-8​3.1​333-2889380​07/25/2025​​3.2​Conformed version of By-Laws, as amended by the Certificate of Amendment to the By-laws, effective November 7, 2024​S-1​3.2​333-283315​11/19/2024​​10.1​Separation Agreement, dated June 16, 2025, by and between Applied DNA Sciences, Inc. and Dr. James A. Hayward​8-K​10.1​001-36745​06/17/2025​​31.1*​Certification of Chief Executive Officer, pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X31.2*​Certification of Chief Financial Officer, pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X32.1**​Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X32.2**​Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X101 INS*​Inline XBRL Instance Document​​​​​​​​​X101 SCH*​Inline XBRL Taxonomy Extension Schema Document​​​​​​​​​X